Join
Live feed
·
INSIDERFilingvia Quantisnow
Atrium Therapeutics Inc. logo

Director Kaye Edward M. Md was granted 6,692 shares (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
RNA· Atrium Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track RNA (Atrium Therapeutics Inc.) and more on Quantisnow.

Director Kaye Edward M. Md was granted 6,692 shares (SEC Form 4) | Quantisnow